42 /100
MEDIUM RISK
Score updated May 30, 2026

LXEO — Lexeo Therapeutics, Inc. Dilution Risk Tracker

Track LXEO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LXEO — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
10
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
20%
📉 Score Deterioration 40%
• Score rose 21 points recently (worsening)
🔔 Track LXEO — Get forecast alerts →

💹 Market Data

Market Cap$403.60M
Shares Outstanding78.52M
Float47.53M
Cash$193.04M
Debt$7.37M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 57.7% shares (2025Q4 vs prior)
144 institutional holders · 78.02M shares
#1 JANUS HENDERSON GROUP PLC 5.51M shares
#2 RA CAPITAL MANAGEMENT, L.P. 5.00M shares
#3 BlackRock, Inc. 4.91M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest13.21M
Days to Cover18.8
% of Float27.8%
FINRA data as of May 15, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2023
4 INSIDER TRANSACTION Apr 30, 2026
8-K 8K EVENT Apr 30, 2026
3 FORM3 Apr 30, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track LXEO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LXEO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for LXEO
📊 LXEO FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 LXEO Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.